Five Prime Therapeutics, Inc. misses by $0.03, misses on revenue

|About: Five Prime Therapeutics, ... (FPRX)|By:, SA News Editor

Five Prime Therapeutics, Inc. (FPRX): Q4 EPS of -$0.43 misses by $0.03.

Revenue of $3.78M misses by $0.05M.